IDYA vs. IOVA
IDYA (IDEAYA Biosciences, Inc.) and IOVA (Iovance Biotherapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, IDYA returned 7.70%/yr vs -28.82%/yr for IOVA. Their 0.34 correlation means their historical movements had little consistent relationship.
Performance
IDYA vs. IOVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDYA achieves a 2.69% return, which is significantly lower than IOVA's 49.08% return.
IDYA
- 1D
- -2.47%
- 1M
- -5.71%
- 6M
- 10.28%
- YTD
- 2.69%
- 1Y
- 46.27%
- 3Y*
- 16.57%
- 5Y*
- 7.70%
- 10Y*
- —
- ALL TIME*
- 13.82%
IOVA
- 1D
- -13.22%
- 1M
- -5.57%
- 6M
- 59.61%
- YTD
- 49.08%
- 1Y
- 51.87%
- 3Y*
- -17.28%
- 5Y*
- -28.82%
- 10Y*
- -7.29%
- ALL TIME*
- -18.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $27.31M | $34.35M | $36.45M | |
| $68.89M | $75.72M | $64.68M |
IDYA vs. IOVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IDYA IDEAYA Biosciences, Inc. | 2.69% | 34.51% | -27.77% | 95.82% | -23.14% | 68.86% | 86.67% | -46.43% |
IOVA Iovance Biotherapeutics, Inc. | 49.08% | -63.11% | -8.98% | 27.23% | -66.53% | -58.86% | 67.63% | 66.45% |
Correlation
The correlation between IDYA and IOVA is 0.40, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.40 |
Correlation (3Y) Balances recent behavior with more history. | 0.44 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.45 |
Correlation (All Time) Calculated using the full available price history since May 23, 2019 | 0.34 |
The correlation between IDYA and IOVA shifts across timeframes, from 0.34 (all time) to 0.45 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
IDYA:
$3.38B
IOVA:
$1.82B
IDYA:
-$1.57
IOVA:
-$0.89
IDYA:
14.02
IOVA:
5.65
IDYA:
3.36
IOVA:
2.36
IDYA:
$225.27M
IOVA:
$285.61M
IDYA:
$215.25M
IOVA:
$327.04M
IDYA:
-$157.90M
IOVA:
-$325.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDYA vs. IOVA — Risk / Return Rank
IDYA
IOVA
IDYA vs. IOVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IDYA | IOVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.32 | ||
| Sortino ratioReturn per unit of downside risk | -0.05 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.18 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.70 | 1.50 | +0.19 |
| Martin ratioReturn relative to average drawdown | 3.68 | 2.64 | +1.03 |
Loading charts...
Drawdowns
IDYA vs. IOVA - Drawdown Comparison
The maximum IDYA drawdown since its inception was -78.36%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for IDYA and IOVA.
Loading charts...
Drawdown Indicators
| IDYA | IOVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.36% | -99.37% | +21.01% |
Max Drawdown (1Y)Largest decline over 1 year | -27.10% | -39.00% | +11.90% |
Max Drawdown (3Y)Largest decline over 3 years | -69.23% | -90.50% | +21.27% |
Max Drawdown (5Y)Largest decline over 5 years | -69.42% | -93.99% | +24.57% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.84% | — |
Current DrawdownCurrent decline from peak | -24.68% | -97.44% | +72.76% |
Average DrawdownAverage peak-to-trough decline | -32.21% | -84.27% | +52.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.49% | 22.14% | -9.65% |
Volatility
IDYA vs. IOVA - Volatility Comparison
The current volatility for IDEAYA Biosciences, Inc. (IDYA) is 13.09%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 30.69%. This indicates that IDYA experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDYA | IOVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.09% | 30.69% | -17.60% |
Volatility (6M)Calculated over the trailing 6-month period | 35.77% | 66.41% | -30.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.73% | 93.87% | -45.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.55% | 90.78% | -32.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.95% | 81.92% | -7.97% |
Dividends
IDYA vs. IOVA - Dividend Comparison
Neither IDYA nor IOVA has paid dividends to shareholders.
Financials
IDYA vs. IOVA - Financials Comparison
This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IDYA and IOVA have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IOVA has higher volatility (30.69%) compared to IDYA (13.09%). In terms of maximum drawdown, IDYA dropped -78.36% vs IOVA's -99.37%.
IDYA currently has the higher Sharpe Ratio (0.95 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDYA and IOVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer